Endurant Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-33,191
| Closed | -$2.99M | – | 83 |
|
|
2021
Q4 | $2.99M | Buy |
+33,191
| New | +$2.99M | 0.72% | 30 |
|
|
2021
Q3 | – | Sell |
-28,625
| Closed | -$2.23M | – | 61 |
|
|
2021
Q2 | $2.23M | Buy |
+28,625
| New | +$2.23M | 0.61% | 44 |
|
|
2021
Q1 | – | Sell |
-28,378
| Closed | -$4.84M | – | 73 |
|
|
2020
Q4 | $4.84M | Buy |
+28,378
| New | +$4.84M | 1.74% | 25 |
|
|
2020
Q1 | – | Sell |
-39,822
| Closed | -$5.14M | – | 65 |
|
|
2019
Q4 | $5.14M | Buy |
+39,822
| New | +$5.14M | 1.62% | 20 |
|
|
2019
Q3 | – | Sell |
-3,753
| Closed | -$570K | – | 58 |
|
|
2019
Q2 | $570K | Sell |
3,753
-10,611
| -74% | -$1.61M | 0.22% | 46 |
|
|
2019
Q1 | $1.71M | Sell |
14,364
-7,251
| -34% | -$864K | 0.68% | 42 |
|
|
2018
Q4 | $2.36M | Buy |
21,615
+13,159
| +156% | +$1.44M | 1.25% | 25 |
|
|
2018
Q3 | $1.37M | Buy |
8,456
+1,742
| +26% | +$281K | 0.61% | 39 |
|
|
2018
Q2 | $887K | Buy |
+6,714
| New | +$887K | 0.38% | 48 |
|
|
2018
Q1 | – | Sell |
-48,800
| Closed | -$2.72M | – | 82 |
|
|
2017
Q4 | $2.72M | Sell |
48,800
-18,500
| -27% | -$1.03M | 0.83% | 44 |
|
|
2017
Q3 | $3.05M | Buy |
+67,300
| New | +$3.05M | 0.93% | 37 |
|
|
2017
Q1 | – | Sell |
-8,400
| Closed | -$230K | – | 97 |
|
|
2016
Q4 | $230K | Buy |
+8,400
| New | +$230K | 0.1% | 68 |
|